Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

17 results
Display

Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-Line Helicobacter pylori Eradication Therapy Administered with Bismuth

Kim JY, Lee SY, Kim H, Kim JH, Sung IK, Park HS

Purpose: To determine the efficacy of a potassium-competitive acid blocker (P-CAB)-based first-line eradication therapy with bismuth compared with that of proton pump inhibitor-based first-line therapy with bismuth. Materials and Methods: Eradication-naive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis

Kim SE, Jung HK, Kang SJ, Lee YC, Yang HJ, Park SY, Shin CM, Lim HC, Kim JH, Nam SY, Shin WG, Park JM, Choi IJ, Kim JG, Choi M, Korean College of Helicobacter and Upper Gastrointesinal Research

Background/Aims: The eradication rate of the first-line standard triple therapy (STT) for Helicobacter pylori (H. pylori) infection has decreased since 2000; therefore, other first-line therapies are required. This study was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam

Van Khien , Thang DM, Hai TM, Duat NQ, Khanh PH, Ha DT, Binh TT, Dung HD, Trang TT, Yamaoka Y

Antibiotic resistance is the most important factor leading to the failure of eradication regimens. This review focuses on the prevalence of Helicobacter pylori primary and secondary resistance to clarithromycin, metronidazole,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study

Kim EJ, Lee OY, Lee KN, Lee SJ, Jang JY, Cho JW, Kim TO

  • KMID: 2454639
  • J Neurogastroenterol Motil.
  • 2019 Jul;25(3):403-412.
  • doi: 10.5056/jnm18185
BACKGROUND/AIMS: Proton pump inhibitors (PPIs) are frequently used to treat non-erosive reflux disease (NERD), but their effect is limited. It is not known whether a potential alternative, AlbisD, containing ranitidine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line Helicobacter pylori Eradication Therapy

Kim SE, Roh JH, Park MI, Park SJ, Moon W, Kim JH, Jung K, Heo JJ

BACKGROUND/AIMS: Both bismuth-containing quadruple therapy and moxifloxacin-containing triple therapy have been suggested as second-line eradication therapy for Helicobacter pylori (H. pylori) infection. We aimed to evaluate the efficacy of 14-day...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication

Kwon S, Lee DH, Kang JB, Kim N, Park YS, Shin CM, Yoon H, Choi YJ

BACKGROUND/AIMS: Moxifloxacin-based sequential therapy showed an excellent eradication rate as the first line treatment of Helicobacter pylori (H. pylori) infection. However, to the best of our knowledge, there were only...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection

Lee ST, Lee DH, Lim JH, Kim N, Park YS, Shin CM, Jo HJ, Song IS

BACKGROUND/AIMS: Bismuth-containing quadruple and moxifloxacin-based triple regimens are recommended as second-line therapy for Helicobacter pylori infection. The aim of this study was to compare the efficacy of each regimen. METHODS: From...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection

Han IW, Jang JY, Kang MJ, Kwon W, Park JW, Chang YR, Kim SW

PURPOSE: Extended liver resection may provide long-term survival in selected patients with Bismuth type IV hilar cholangiocarcinoma (HCCA). The purpose of this study was to identify anatomical factors that predict...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Newly Designed Y-shaped Covered Stent in the Palliative Treatment of Hepatic Hilar Malignant Obstruction: Case Report

Kang BC, Lee SY, Chung HH

We report a case in an inoperable patient with the hilar malignant biliary obstruction treated palliatively by the use of a newly designed Y-shaped covered stent without interfering contra-lateral bile...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication

Yoon JH, Baik GH, Kim YS, Suk KT, Shin WG, Kim KH, Kim KO, Park CH, Baik IH, Jang HJ, Kim JB, Kae SH, Kim DJ, Kim HY

  • KMID: 2167412
  • Gut Liver.
  • 2012 Oct;6(4):434-439.
BACKGROUND/AIMS: First-line therapies against Helicobacter pylori, including proton pump inhibitors (PPIs) plus two antibiotics, may fail in up to 20% of patients. 'Rescue' therapy is usually needed for patients who...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Drug-induced Skin Hyperpigmentation after Usual Dosage of Bismuth-Containing Compound Medication in a Kidney Transplant Patient

Choi W, Choi H, Jung JY, Chang JH, Chung W, Lee HH

  • KMID: 2142013
  • Korean J Nephrol.
  • 2011 Nov;30(6):682-685.
A 59-year-old male presented with multiple hyperpigmented skin with hyperkeratotic scaly patches on hands, feet and face. Bismuth containing compound had been prescribed two months before then due to epigastric...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Efficacy of Bismuth Containing PPI-based Quadruple Therapy with PPI-based Triple Therapy Only as First-line Treatment for Helicobacter pylori Infection

Jo HJ, Lee DH, Kang SJ, Kim MN, Kim SH, Park JM, Choi MS, Jung HC, Song IS, Kim N, Jung SH, Kim JW, Park YS, Lee SH

  • KMID: 2084530
  • Korean J Gastrointest Endosc.
  • 2008 Oct;37(4):259-264.
BACKGROUND/AIMS: In recent years, increasing antimicrobial resistance has resulted in falling eradication rates with standard therapies. To overcome the falling eradication rates, rescue therapy have been suggested to be used....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Two Triple Eradication Regimens in Children with Helicobacter pylori Infection

Choi J, Jang JY, Kim JS, Park HY, Choe YH, Kim KM

Triple therapy with bismuth subsalicylate, amoxicillin, metronidazole (BAM) or with omeprazole, amoxicillin, clarithromycin (OAC) has been commonly used for the eradication of Helicobacter pylori infection. We compared the efficacy of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two Cases of Gastric Mucosal Calcinosis

Yeo JC, Ju DU, Lee SY, Eum SW, Lee JH, Kim SH, Park CK, Lee SY, Kim HS, Koo MJ

  • KMID: 2143660
  • Korean J Gastrointest Endosc.
  • 2006 Oct;33(4):230-234.
Gastric mucosal calcinosis (GMC) is a very rare condition that is characterized by the nodular deposition of calcium salts in the gastric mucosa. It has been associated with renal failure,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of One - week Triple Therpy of Ranitidine Bismuth Citrate , Amoxicillin and Clarithromycin in Helicobacter pylori - related Peptic Ulcer Patients

Lee KM, Lee DS, Ahn BM, Song HJ, Kim SW, Han SW, Chung IS, Sun HS, Park DH

  • KMID: 2240234
  • Korean J Gastroenterol.
  • 2001 Jun;37(6):412-417.
BACKGROUND/AIMS: We performed this study to investigate the efficacy and safety of one-week triple therapy consisted of ranitidine bismuth citrate (RBC), amoxicillin and clarithromycin in the treatment of H. pylori-related...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy of Ranitidine Bismuth Citrate, Clarithromycin, Amoxicillin for Eradication of Helicobacter Pylori with Peptic Ulcer Disease

Kim YS, Son HY, Jung HK, Yi SY

OBJECTIVES: Helicobacter pylori(H. pylori) infection causes an active chronic gastritis and is an important etiological factor in developement of peptic ulcers. Successful treatment of this infection heals ulcers and reduces...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy of Ranitidine Bismuth Citrate plus Clarithromycin for the Eradication of Helicobacter pylori and the Healing of Duodenal Ulcer

Park SM, Hong WS, Kim JG, Kim JH

  • KMID: 2240348
  • Korean J Gastroenterol.
  • 2000 Apr;35(4):429-438.
BACKGROUND/AIMS: To assess the safety and the efficacy of the combined therapy of ranitidine bismuth citrate (RBC) with clarithromycin on the eradication of Helicobacter pylori (H. pylori) and the healing of duodenal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr